Adjuvant chemotherapy in node-negative breast cancer. NCI consensus conference

Affiliations

Review

G Bonadonna. Eur J Cancer. 1990.

. 1990;26(7):844-5.

doi: 10.1016/0277-5379(90)90168-s.

No abstract available

Similar articles

Adjuvant chemotherapy for node-positive breast cancer patients: which is the reference today?
Fumoleau P, Bonneterre J, Luporsi E. Fumoleau P, et al. J Clin Oncol. 2003 Mar 15;21(6):1190-1; author reply 1191-2. doi: 10.1200/JCO.2003.99.223. J Clin Oncol. 2003. PMID: 12637489 No abstract available.
Adjuvant therapy for node-negative breast cancer: a proactive view.
Glick JH. Glick JH. Important Adv Oncol. 1990:183-97. Important Adv Oncol. 1990. PMID: 2182518 Review. No abstract available.
Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
Henderson IC. Henderson IC. Important Adv Oncol. 1990:199-216. Important Adv Oncol. 1990. PMID: 1691137 Review. No abstract available.
Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Kunkler I. Kunkler I. J Natl Cancer Inst. 2005 Aug 3;97(15):1162-3; author reply 1163-4. doi: 10.1093/jnci/dji216. J Natl Cancer Inst. 2005. PMID: 16077078 No abstract available.
Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z, Li J, Wang T, Xie Y, Fan T, Lin B, Ouyang T. Fan Z, et al. Breast. 2013 Dec;22(6):1161-5. doi: 10.1016/j.breast.2013.08.004. Epub 2013 Sep 27. Breast. 2013. PMID: 24080493

Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer.
Gasparini G, Bevilacqua P, Pozza F, Meli S, Boracchi P, Marubini E, Sainsbury JR. Gasparini G, et al. Br J Cancer. 1992 Nov;66(5):970-6. doi: 10.1038/bjc.1992.394. Br J Cancer. 1992. PMID: 1419645 Free PMC article.